SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001785530-21-000011
Filing Date
2021-05-28
Accepted
2021-05-28 08:06:07
Documents
2
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162220355183533.html 3  
1 FORM 3 wf-form3_162220355183533.xml 3 1738
2 M. SHERMAN POA shermanpoa.htm EX-24 4353
  Complete submission text file 0001785530-21-000011.txt   7478
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address
Sherman Michael A. (Reporting) CIK: 0001509463 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21976214

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations